Thursday, March 14, 2013

Industry Groups Urge Lawmakers To Address Trade Policies With India's Regulators.

Reuters (3/14, Palmer) reports executives from agricultural, pharmaceutical and technology industries on Wednesday, called for the US government to step up pressure on India to revise its trade and intellectual property policies, which the industry reps claim are stifling US exports and violating its patent rights. In testimony before the House Ways and Means trade subcommittee, Pfizer's Chief Intellectual Property Counsel Roy Waldron said the protectionist policy India has developed to enable its generic drug makers to thrive is hurting US employment growth. He cited several examples, such as India's revocation of the patent Pfizer held on the cancer treatment Sutent (sunitinib malate), emphasizing the country's tendency to dissolve drug patents by issuing compulsory licenses, which are supposed to be awarded only in certain situations. Waldron concluded his testimony by urging Federal lawmakers to address those issues actively, though direct talks with Indian regulators and to use available policy standards to compel India to honor intellectual property rights.

DIA DailyDIA Daily. This daily enewsletter features summaries of breaking news and information about the pharmaceutical, biotechnology, and medical device fields from thousands of global news sources. This easy-to-read enewsletter is delivered to your inbox every business morning.

Subscribe to the DIA Daily.
View archives.
iPhone and iPad Apps available! Download "BulletinHC."
DIA Daily is a digest of the most important news selected from thousands of sources by the editors of BulletinHealthcare. The presence of content or advertising does not endorse, nor imply endorsement of, any products or services by the Drug Information Association. Neither BulletinHealthcare nor the Drug Information Association is liable for the use of or reliance on any information contained in this briefing.

If you would like more information about, or have a question pertaining to, DIA Membership and its benefits, please email here to check your membership status.

Drug Information Association | 800 Enterprise Road, Suite 200 | Horsham, PA 19044
Copyright © 2012 by BulletinHealthcare| 11190 Sunrise Valley Drive, Suite 130 | Reston, VA 20191

No comments:

Post a Comment